FibroGen, Inc. (FGEN)
8.84
+0.34
(+3.94%)
USD |
NASDAQ |
Dec 10, 16:00
8.84
0.00 (0.00%)
After-Hours: 17:04
FibroGen Total Liabilities (Quarterly): 119.53M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 213.97M |
| Perspective Therapeutics, Inc. | 52.61M |
| Skye Bioscience, Inc. | 8.488M |
| Theravance Biopharma, Inc. | 182.78M |
| Myomo, Inc. | 19.45M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 137.01M |
| Shareholders Equity (Quarterly) | -17.03M |
| Debt to Equity Ratio | -1.236 |
| Current Ratio | 3.709 |
| Net Debt Paydown Yield | 57.66% |